WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
PR & Media
Strategic support to drive communications programmes and build visibility
Marketing
Effectively promote products and services to generate leads
Design & Branding
Elevate company image with bespoke design services for websites and corporate materials
Investor Relations
Strengthen relationships with investors through targeted outreach

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
ASHG – American Society of Human Genetics – Annual Meeting 2026
-
Innovate Cambridge Summit 2026
-
ESMO – European Society For Medical Oncology – Congress 2026
-
The ESGCT – European Society of Gene and Cell Therapy -33rd Annual Congress
Takara Bio USA Partners with SPT Labtech to Deliver Automation-Ready NGS Library Preparation Technologies
Trusted NGS chemistries from Takara Bio now optimized for firefly® automated workflows San Jose, California, and Cambridge, UK, 20 October 2026: Takara Bio USA, Inc., a wholly owned subsidiary of [...]
ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics
Cambridge, UK, 20 October 2026: ScionxBio (the “company”, operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA [...]
Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands
Celea has now contracted Qureight as the end-to-end imaging CRO for the phase 3 SURPASS-IPF trial, including Fibr8™ and four additional AI imaging models Joint poster at CHEST 2026 presents [...]
























